CIPLA Share Price Today: Why CIPLA Is Rising 2.09% | 18 November 2026

NSE: CIPLA · 18 November 2026

Price
₹1,417.00
Change
+2.09%
High / Low
₹1,435.00 / ₹1,381.30
Prev. Close
₹1,388.00
Volume
29.09 lakh
Price as of
18 November 2026 · 03:30 PM IST
WittyTrades F&O Stock Intelligence

CIPLA LTD F&O Intelligence

Data-mining view of cash participation, delivery, futures activity, open interest and recent positioning.

Latest completed-session snapshot
Cash closeRs 1,417.00+2.09%
Cash openRs 1,390.00
Cash high / lowRs 1,435.00 / Rs 1,381.30
Near futureRs 1,421.80+2.40%
All-expiry futures OI1.12 Cr shares+0.68%
F&O/Cash participation ratio2.29xWittyTrades Proprietary
WittyTrades Proprietary Metrics
Shares Traded per Trade40.03-session average: 32.3. Formula: cash shares traded ÷ number of trades.
F&O/Cash Participation Ratio2.29xFormula: futures-equivalent shares ÷ cash shares. 3-session trend: 0.58x → 1.23x → 2.29x.

NSE cash-market participation

Last 3 Sessions: Cash Activity & Delivery

Date Cash Volume Number of Trades Shares Traded per Trade Delivery % Close / Change
16 Nov 12.49 L shares 41,090 30.4
WittyTrades Proprietary
60.50% Rs 1,394.50 (+0.19%)
17 Nov 10.17 L shares 38,265 26.6
WittyTrades Proprietary
62.34% Rs 1,388.00 (-0.47%)
18 Nov 29.09 L shares 72,754 40.0
WittyTrades Proprietary
33.26% Rs 1,417.00 (+2.09%)
WittyTrades Proprietary Metric: Large-Ticket Activity Proxy
Average number of shares traded per trade was 40.0 in the latest session versus a 32.3 3-session average. The latest average trade size was materially above its 3-session baseline, which can flag stronger larger-ticket or institutional-style participation. Latest delivery was 33.3% versus a 3-session average of 52.0%.
Futures participation

Last 3 Sessions: Futures vs Cash Participation

Date Near Future / Change Futures Volume (Shares) Cash Volume (Shares) F&O/Cash Participation Ratio Aggregate Futures OI Positioning Read
16 Nov Rs 1,398.20 (-0.02%) 7.21 L shares 12.49 L shares 0.58x
WittyTrades Proprietary
1.09 Cr shares (—) Positioning unavailable
17 Nov Rs 1,388.50 (-0.69%) 12.54 L shares 10.17 L shares 1.23x
WittyTrades Proprietary
1.12 Cr shares (+2.18%) Short buildup
18 Nov Rs 1,421.80 (+2.40%) 66.57 L shares 29.09 L shares 2.29x
WittyTrades Proprietary
1.12 Cr shares (+0.68%) Long buildup
Participation read: Futures-equivalent volume was 2.29 times cash-market share volume in the latest completed session. The latest price/OI classification is Long buildup. Classification uses aggregate all-expiry OI to reduce front-month rollover distortion.
Expiry & contract migration

How open interest shifted across expiries

Expiry Latest OI 1-Day OI Change
23 Nov 72.40 L shares -24.90 L
29 Dec 37.79 L shares +25.69 L
25 Jan 2.29 L shares -2,975

The front expiry lost OI while later expiries gained OI, confirming contract migration. About 35.6% of aggregate OI sat beyond the front expiry. This is an expiry-structure observation, not a directional signal by itself.

What to monitor next

  • Whether aggregate futures OI expands or contracts alongside the next price move.
  • Whether the WittyTrades F&O/Cash Participation Ratio remains elevated or normalises.
  • Whether Shares Traded per Trade moves materially above or below its recent baseline.
  • Whether delivery participation holds above or below the recent 3-session average of 52.0%.
  • Whether later-expiry OI continues to absorb positions from the front contract as expiry approaches.

Higher Shares Traded per Trade can flag larger-ticket participation, but exchange trade-count data does not identify the buyer or seller category. The F&O/Cash Participation Ratio measures participation intensity and does not by itself distinguish directional trading, hedging or arbitrage.

Key Takeaways
  • Cipla Ltd shares advanced 2.09% during the trading session, settling at ₹1,417.00 after moving between an intraday low of ₹1,381.30 and a high of ₹1,435.00.
  • Cipla provided an official update regarding the USFDA inspection at its InvaGen manufacturing facility located in Hauppauge, Long Island, New York, USA. The disclosure follows prior regulatory engagements concerning the overseas manufacturing plant.
  • Trading volume was 1.98 times the 20-day average daily volume.

Why is CIPLA share price rising on 18 November 2026?

Cipla Ltd shares advanced 2.09% during the trading session, settling at ₹1,417.00 after moving between an intraday low of ₹1,381.30 and a high of ₹1,435.00.

The broader market faced downward pressure as the Nifty index declined 0.63%, while the sectoral benchmark Nifty Pharma posted a modest gain of 0.15%. Cipla outperformed both the broader index and its sector peers, supported by a healthy pickup in cash-market participation and strong relative strength compared to the wider pharmaceutical basket.

On the corporate front, market participants noted the ongoing operational developments surrounding the company, including recent updates regarding regulatory inspections at its overseas manufacturing facilities and management additions. While these ongoing updates provide broader business context, today's positive price action reflects solid buying interest and accumulation rather than a single immediate catalyst.

29.09 lakh shares traded by 18 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 14.70 lakh shares (1.98 times). The five-day average daily volume was 13.39 lakh shares. Separately, the NSE report for 18 November 2026 showed 9.68 lakh shares delivered, representing 33.26% of that day’s traded volume. The same report recorded 72,754 trades.

Likely Reason
Stock-specific accumulation and sector outperformance

The upward move occurred amid higher-than-average cash volume and relative strength against a falling broader market, though no single same-day catalyst was explicitly linked to the session's gains.

Latest Company Developments

USFDA Inspection Update for InvaGen Facility
18 November 2026

Cipla provided an official update regarding the USFDA inspection at its InvaGen manufacturing facility located in Hauppauge, Long Island, New York, USA. The disclosure follows prior regulatory engagements concerning the overseas manufacturing plant.

Regulatory compliance and facility audits at key international plants are critical for maintaining uninterrupted export operations and sustaining growth in the US generics market.

Appointment of Senior Management Personnel
4 November 2026

The company announced the appointment of Mr. Vikram Janakiraman as the Global Chief Technical Operating Officer, designated as a Senior Management Personnel effective from December 7, 2026. This addition aims to bolster operational and technical execution across global manufacturing networks.

Senior leadership changes in technical and operational roles are key to overseeing manufacturing excellence and navigating regulatory standards across key global markets.

General Updates
18 November 2026

Update on USFDA inspection at InvaGen manufacturing facility in Hauppauge, Long Island, NewYork, USA

Earnings / operating update
27 October 2026

a press release dated October 27, 2026, titled "Q2FY27 Financial Results".

Management / board update
27 October 2026

Appointment of Ms Rashmi Joshi as Independent Director of the company effective. October 27, 2026.

Ownership & Transaction Activity

Shareholding
As of 30 September 2026
Promoter holding
29.21%
29.21% on 30 June 2026
FII/FPI
20.25%
20.21% on 30 June 2026
Institutional holding
55.19%
54.84% on 30 June 2026
Historical Insider Activity
Renu Jain jointly with Dinesh JainImmediate relative
TransactionBuy
Quantity15,419 shares
Trade date26 September 2025
Anusha Jain jointly with Dinesh JainImmediate relative
TransactionSell
Quantity15,419 shares
Trade date26 September 2025
Source: NSE transaction disclosures. These are dated historical transactions.

Mutual Fund Holdings

Mutual-fund ownership

Mutual funds held 20.78% on 30 September 2026. This compares with 20.56% on 30 June 2026, a change of +0.22 percentage points.

The filing reported 46 MF/UTI holders.

HDFC MUTUAL FUND – HDFC FOCUSED FUND
30 September 2026
3.24 crore shares · 4.03%
SBI ELSS TAX SAVER FUND
30 September 2026
2.75 crore shares · 3.41%
ICICI PRUDENTIAL NIFTY50 EQUAL WEIGHT INDEX FUND
30 September 2026
2.33 crore shares · 2.89%
These are quarterly holdings, rather than purchases or sales on the article date.

What to Watch Next

  • Developments regarding the USFDA inspection status at the InvaGen manufacturing facility
  • Cash volume and delivery percentage trends relative to the 20-day average volume
  • Performance against the Nifty Pharma sector benchmark
  • Execution of operational goals under incoming senior technical management

Other Dated Coverage

More CIPLA news and dated analysis →

Frequently Asked Questions

What is the latest CIPLA company news?

Cipla provided an official update regarding the USFDA inspection at its InvaGen manufacturing facility located in Hauppauge, Long Island, New York, USA. The disclosure follows prior regulatory engagements concerning the overseas manufacturing plant.

How strong was CIPLA’s trading volume?

29.09 lakh shares traded, 1.98 times the 20-day average daily volume. The price and volume data are dated 18 November 2026 · 03:30 PM IST.

Do the mutual-fund figures show buying today?

They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.

Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
SEBI Registration No.: INH000008172 · BSE Enlistment No.: 5430

Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top